
|Articles|February 6, 2004
New fillers expanding patients' options
With a handful of new options expected to receive FDA approval withina year, the field of tissue augmentation stands poised to undergo a seismicshift. "The bottom line is, tissue augmentation is about to changedramatically," said Mariano E. Busso, M.D. He is clinical professorin the University of Miami's department of dermatology, chief of dermatologyat Mercy Hospital, also in Miami, Fla., and a private practitioner who isboard-certified in dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
3
Introducing Dermatology Times NP/PA Connect
4
Narrow-Spectrum Sarecycline Approved for Moderate to Severe Acne in China
5











